Styrelsen för C-RAD AB (publ) (”C-RAD” eller ”Bolaget”) har upprättat ett tilläggsprospekt till det prospekt som offentliggjordes den 12 december 2014 med anledning av notering av Bolagets aktier på Nasdaq Stockholm. Tilläggsprospektet har upprättats med anledning av pressmeddelande som C-RAD offentliggjorde idag den 15 december 2014. Tilläggsprospektet har idag godkänts och registrerats av Finansinspektionen och finns tillgängligt på www.c-rad.com och på www.penser.se .
Uppsala den 15 december 2014
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666947, E-mail investors@c-rad.com
The above information is price sensitive and must therefore be disclosed under the Securities Market Act (2077:528).
About C-RAD
C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Numbers of employees are currently 28 people. The activities in C-RAD AB originate from research and development at the Karolinska Institutet in Solna. Sales of the company’s first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with the Swedish company Elekta, the US company Varian and the Belgian company IBA. C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has founded three companies for direct sales, C-RAD Incorporated in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. C-RAD has invested in 29 % of the laser company Cyrpa and with an option to acquire the remaining 71 %. C-RAD AB is since March 2010 listed at Nasdaq First North Premier. Erik Penser Bankaktiebolag is appointed as C-RAD’s Certified Adviser.
For more information on C-RAD, please visit www.c-rad.com.
